Last edition
News about "Invasive meningococcal disease "
European Commission Expands Sanofi's MenQuadfi Approval to Include Infants from Six Weeks of Age
The European Commission has approved an expanded indication for Sanofi's MenQuadfi vaccine, allowing immunisation of infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y.
Invasive Meningococcal Disease | 05/08/2026 | By News Bureau
European Commission Expands Sanofi's MenQuadfi Approval to Include Infants from Six Weeks of Age
The European Commission has approved an expanded indication for Sanofi's MenQuadfi vaccine, allowing immunisation of infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y.
Invasive Meningococcal Disease | 05/08/2026 | By News Bureau
SIIPL Signs Licensing Agreement with University of Oxford for Meningitis-B Vaccine
Serum Institute of India Pvt. Ltd. (SIIPL) and the University of Oxford have formalised a Licence of Technology Agreement negotiated by Oxford University Innovation in a significant stride towards addressing the challenge of Men-B disease.
Invasive Meningococcal Disease | 22/04/2024 | By Aishwarya | 739
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy